Sling Therapeutics

Sling Therapeutics

Biotechnology

Ann Arbor, MI 1,262 followers

Focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease (TED).

About us

We are a clinical-stage biopharmaceutical company developing an oral small molecule for the treatment of thyroid eye disease (TED). Our team consists of highly experienced drug developers, supplemented by global experts through our Scientific Advisory Board.

Industry
Biotechnology
Company size
2-10 employees
Headquarters
Ann Arbor, MI
Type
Privately Held
Specialties
Life sciences, biotechnology, pharmaceuticals, Thyroid Eye Disease, Autoimmune, Endocrinology, Ophthalmology, Hyperthyroidism, clinical research, clinical study, research, small molecule, molecular engineering, chemistry, patient advocacy, drug development, clinical development, immune system, Graves' disease, and fibroblast

Locations

Employees at Sling Therapeutics

Updates

Similar pages

Funding

Sling Therapeutics 1 total round

Last Round

Series A

US$ 35.0M

Investors

The Rise Fund
See more info on crunchbase